FDA Regulation of Laboratory Developed Tests Will Improve Patient Safety
Updated August 4, 2014
Updated August 4, 2014
WASHINGTON, D.C. -- July 29, 2014 -- Following is a statement from John R.
WASHINGTON, D.C. July 28, 2014 The U.S. House of Representatives passed the Sunscreen Innovation Act today paving the way for the Food and Drug Administration (FDA) to review and approve new sunscreen ingredients for the first time in more than a decade.
WASHINGTON July 22, 2014 The nation 's leading groups representing patients with and survivors of cancer, diabetes, heart disease and stroke issued the following statement today in response to the decision by the U.S. Court of Appeals for the D.C. Circuit in the case of Halbig v. Burwell.
WASHINGTON July 22, 2014 Below is a joint statement of the American Cancer Society, American Cancer Society Cancer Action Network, American Diabetes Association and American Heart Association in response to the decision of the U.S. Court of Appeals for the 4th Circuit:
WASHINGTON, D.C. July 21, 2014 Following is a statement from Chris Hansen, president of the American Cancer Society Cancer Action Network (ACS CAN), in reaction to a Florida jury award of $23 billion in punitive damages to widow Cynthia Robinson in her lawsuit against R.J.
WASHINGTON, DC More than 30 colon and rectal cancer advocates and survivors are on Capitol Hill today calling for members of Congress to support legislation to ensure that cost is not a barrier for Medicare beneficiaries trying to access lifesaving colon cancer screenings.
The report, Achieving Balance in State Pain Policy: A Progress Report Card (CY 2013)æshows the extent that state policies can support pain management and patient care.
Patients must be the focus of innovation and they must also be active partners in all aspects of research, development and regulation of new therapies, testified Leonard Lichtenfeld, M.D., deputy chief medical officer of the American Cancer Society, before the House Energy and Commerce Subcommittee on Health today.
WASHINGTON, D.C. July 10, 2014 Following is a statement from John Seffrin, chief executive officer of the American Cancer Society and its advocacy affiliate, the American Cancer Society Cancer Action Network (ACS CAN), on the departure of Howard K.